Immunocore (IMCR) Competitors

Immunocore (NASDAQ:IMCR) and Elanco Animal Health (NYSE:ELAN) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

Which has better valuation & earnings, IMCR or ELAN?

Immunocore has higher earnings, but lower revenue than Elanco Animal Health. Immunocore is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Immunocore	$333.58M	5.55	-$55.29M	-$0.43	-85.66
Elanco Animal Health	$4.43B	1.60	-$1.23B	$0.74	19.29

Does the MarketBeat Community favor IMCR or ELAN?

Elanco Animal Health received 69 more outperform votes than Immunocore when rated by MarketBeat users. However, 73.53% of users gave Immunocore an outperform vote while only 54.96% of users gave Elanco Animal Health an outperform vote.

Company	Underperform	Outperform
Immunocore	Outperform Votes 75 73.53%	Underperform Votes 27 26.47%
Elanco Animal Health	Outperform Votes 144 54.96%	Underperform Votes 118 45.04%

Does the media prefer IMCR or ELAN?

In the previous week, Immunocore had 7 more articles in the media than Elanco Animal Health. MarketBeat recorded 10 mentions for Immunocore and 3 mentions for Elanco Animal Health. Immunocore's average media sentiment score of 1.11 beat Elanco Animal Health's score of 0.46 indicating that Immunocore is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Immunocore	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Elanco Animal Health	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is IMCR or ELAN more profitable?

Elanco Animal Health has a net margin of 4.60% compared to Immunocore's net margin of -15.87%. Elanco Animal Health's return on equity of 6.78% beat Immunocore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Immunocore	-15.87%	-12.84%	-5.09%
Elanco Animal Health	4.60%	6.78%	3.03%

Do institutionals & insiders believe in IMCR or ELAN?

84.5% of Immunocore shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 10.4% of Immunocore shares are owned by insiders. Comparatively, 0.9% of Elanco Animal Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Which has more volatility and risk, IMCR or ELAN?

Immunocore has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.67, indicating that its share price is 67% more volatile than the S&P 500.

Do analysts rate IMCR or ELAN?

Immunocore currently has a consensus price target of $58.89, indicating a potential upside of 59.87%. Elanco Animal Health has a consensus price target of $15.17, indicating a potential upside of 6.22%. Given Immunocore's stronger consensus rating and higher probable upside, equities analysts plainly believe Immunocore is more favorable than Elanco Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Immunocore	1 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.55
Elanco Animal Health	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43

Summary

Immunocore and Elanco Animal Health tied by winning 9 of the 18 factors compared between the two stocks.